Rituximab as a first-line agent for the treatment of dermatomyositis

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1783-1784

  Haroon, Muhammad ^a   Devlin, Joe ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

Corticosteroids; Dermatomyositis; Rituximab

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CREATINE KINASE; GLUCOCORTICOID; LACTATE DEHYDROGENASE; RHEUMATOID FACTOR; RITUXIMAB;

ADULT; ANTIBODY TITER; ARTHRITIS; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHANGIOLEIOMYOMATOSIS; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYALGIA; PAPULE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; B-LYMPHOCYTES; BIOPSY; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; ELECTROMYOGRAPHY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863874275     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1458-6     Document Type: Article

References (7)

1. Chung L, Genovese MC, Fiorentino DF (2007) A pilot trial of rituximab in the treatment of patients with dermatomyositis. Arch Dermatol 143(6):763-767
2. Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ (2007) Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Arthritis Rheum 56(9):3107-3111
3. Noss EH, haunser-Sypek DL, Weinblatt ME (2006) Rituximab as therapy for refractory polymyositis and dermatomyositis. J Rheumatol 33(5):1021-1026
4. Touma Z, Arayssi T, Kibbi L, Masri AF (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Joint Bone Spine 75(3):334-337
5. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of highdose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993-2000
6. Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjornsson M, Lindvall B, Lundberg IE (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276-1283
7. Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE (2008) A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis 67(12):1670-1677